TB and COVID-19: paying attention to diabetes mellitus.
Trans R Soc Trop Med Hyg
; 115(6): 600-602, 2021 06 02.
Article
in English
| MEDLINE | ID: covidwho-1254841
ABSTRACT
In 2019, global diabetes prevalence was 463 million. Diabetes increases the risk of TB and adverse treatment outcomes including death and relapse. Diabetes also increases the risk of severe disease, multi-organ failure, coagulopathy and death in COVID-19. TB and COVID-19 share many features, suggesting opportunities to integrate prevention, diagnosis and care. Three areas for further work are highlighted better infection control in diabetes clinics, easier and quicker diagnosis using similar technology platforms and optimal blood glucose control. The funding and resources for COVID-19 should be harnessed to improve TB and diabetes care and achieve their respective sustainable development goal targets.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Trans R Soc Trop Med Hyg
Year:
2021
Document Type:
Article
Affiliation country:
Trstmh
Similar
MEDLINE
...
LILACS
LIS